View drug registration information details.


ItemsRegistration information
ID1260
No1260
Brand NameMYOPAS TABLET
IngredientsPARACETAMOL 450 MG, ORPHENADRINE CITRATE 35 MG
Dosage FormTABLET
Primary PackagingALU-ALU STRIP
StorageDO NOT STORE ABOVE 30"C
Shelf Life4 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing CategoryPrescription only
ATC ClassificationXX
Pharmaceutical ClassANALGESICS & ANTI-INFLAMMATORIES
IndicationsFOR THE TREATMENT OF MILD TO MODERATE PAIN INCLUDING HEADACHE, MIGRAINE, NEURALGIA, TOOTHACHE, SORE THROAT, PERIOD PAINS, ACHES AND PAINS, SYMPTOMATIC RELIEF OF RHEUMATIC ACHES AND PAINS AND OF INFLUENZA, FEVERISHNESS AND FEVERISH COLDS.
ContraindicationsHYPERSENSITIVITY TO PARACETAMOL AND ORPHENADRINE CITRATE OR ANY OF THE CONSTITUENTS.
Side EffectsABDOMINAL OR STOMACH CRAMPS, PAIN
Unit Price-
EDL No
DescriptionA WHITE, PILLOW SHAPE, FLAT TABLET WITH A BREAK - LINE ON ONE SIDE
Note
License OwnerKONGCHAI-LAO PHARMA SOLE CO.,LTD
ManufacturerT.MAN PHARMA CO.,LTD
CountryTHAILAND
Import Registration No2A 414/29
Import Registration Date1986-04-29
ActivityCERTIFICATE RELEASED
Applied Date10-มิ.ย.-2024
FDD Registration No05 I 4265/17
FDD Registration Date2024-07-09
Expiry Date2027-07-08

Back to drug list